JP2023514371A5 - - Google Patents

Info

Publication number
JP2023514371A5
JP2023514371A5 JP2022549653A JP2022549653A JP2023514371A5 JP 2023514371 A5 JP2023514371 A5 JP 2023514371A5 JP 2022549653 A JP2022549653 A JP 2022549653A JP 2022549653 A JP2022549653 A JP 2022549653A JP 2023514371 A5 JP2023514371 A5 JP 2023514371A5
Authority
JP
Japan
Prior art keywords
sequence
seq
polypeptide
light chain
chain polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022549653A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023514371A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/018705 external-priority patent/WO2021168194A1/en
Publication of JP2023514371A publication Critical patent/JP2023514371A/ja
Publication of JP2023514371A5 publication Critical patent/JP2023514371A5/ja
Priority to JP2026017499A priority Critical patent/JP2026086568A/ja
Pending legal-status Critical Current

Links

JP2022549653A 2020-02-19 2021-02-19 操作された抗her2二重特異性タンパク質 Pending JP2023514371A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026017499A JP2026086568A (ja) 2020-02-19 2026-02-05 操作された抗her2二重特異性タンパク質

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062978758P 2020-02-19 2020-02-19
US62/978,758 2020-02-19
PCT/US2021/018705 WO2021168194A1 (en) 2020-02-19 2021-02-19 Engineered anti-her2 bispecific proteins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026017499A Division JP2026086568A (ja) 2020-02-19 2026-02-05 操作された抗her2二重特異性タンパク質

Publications (2)

Publication Number Publication Date
JP2023514371A JP2023514371A (ja) 2023-04-05
JP2023514371A5 true JP2023514371A5 (cg-RX-API-DMAC7.html) 2024-02-26

Family

ID=77391704

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022549653A Pending JP2023514371A (ja) 2020-02-19 2021-02-19 操作された抗her2二重特異性タンパク質
JP2026017499A Pending JP2026086568A (ja) 2020-02-19 2026-02-05 操作された抗her2二重特異性タンパク質

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026017499A Pending JP2026086568A (ja) 2020-02-19 2026-02-05 操作された抗her2二重特異性タンパク質

Country Status (13)

Country Link
US (1) US20230192887A1 (cg-RX-API-DMAC7.html)
EP (1) EP4181950A4 (cg-RX-API-DMAC7.html)
JP (2) JP2023514371A (cg-RX-API-DMAC7.html)
KR (1) KR20220156526A (cg-RX-API-DMAC7.html)
CN (1) CN115361972A (cg-RX-API-DMAC7.html)
AR (1) AR121384A1 (cg-RX-API-DMAC7.html)
AU (1) AU2021224200A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022016232A2 (cg-RX-API-DMAC7.html)
CA (1) CA3170338A1 (cg-RX-API-DMAC7.html)
IL (1) IL295729A (cg-RX-API-DMAC7.html)
MX (1) MX2022010161A (cg-RX-API-DMAC7.html)
TW (1) TW202144431A (cg-RX-API-DMAC7.html)
WO (1) WO2021168194A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS63818B1 (sr) 2017-02-17 2023-01-31 Denali Therapeutics Inc Konstruisani polipeptidi za vezivanje za receptor transferina
JP7543290B2 (ja) 2019-02-20 2024-09-02 デナリ セラピューティクス インコーポレイテッド 抗trem2抗体及びその使用方法
CR20230178A (es) 2020-10-14 2023-07-26 Denali Therapeutics Inc Proteínas de fusión que comprenden enzimas sulfoglucosamina sulfohidrolasa y métodos de estas
IL311003A (en) 2021-08-25 2024-04-01 Denali Therapeutics Inc Anti-2HER antibodies and methods of using them
US20240392035A1 (en) * 2021-08-25 2024-11-28 Denali Therapeutics Inc. Engineered anti-her2 bispecific proteins
CN120077064A (zh) * 2022-08-05 2025-05-30 詹森生物科技公司 用于治疗脑肿瘤的转铁蛋白受体结合蛋白
EP4565331A1 (en) * 2022-08-05 2025-06-11 Janssen Biotech, Inc. Cd98 binding constructs for treating brain tumors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005047327A2 (en) * 2003-11-12 2005-05-26 Biogen Idec Ma Inc. NEONATAL Fc RECEPTOR (FcRn)-BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO
US9101674B2 (en) * 2010-03-29 2015-08-11 Vib Vzw Targeting and in vivo imaging of tumor-associated macrophages
LT3074424T (lt) * 2013-11-27 2025-05-26 Zymeworks Bc Inc. Bispecifiniai antigeną surišantys konstruktai, nukreipti į her2
WO2015095412A1 (en) * 2013-12-19 2015-06-25 Zhong Wang Bispecific antibody with two single-domain antigen-binding fragments
JP6510532B2 (ja) * 2013-12-20 2019-05-08 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 二重特異性her2抗体及び使用方法
CA2943299A1 (en) * 2014-04-11 2015-10-15 Medimmune, Llc Bispecific her2 antibodies
US10717783B2 (en) * 2014-12-22 2020-07-21 Zeren Gao Bispecific tetravalent antibodies and methods of making and using thereof
JP7021955B2 (ja) * 2015-06-24 2022-03-03 エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト Her2及び血液脳関門受容体に特異的な三重特異性抗体及び使用方法
CA3053381A1 (en) * 2017-02-17 2018-08-23 Denali Therapeutics Inc. Engineered polypeptides
WO2019032955A1 (en) * 2017-08-10 2019-02-14 Denali Therapeutics Inc. MODIFIED TRANSFERRIN RECEPTOR BINDING POLYPEPTIDES
RU2018111298A (ru) * 2018-03-29 2019-10-01 Закрытое Акционерное Общество "Биокад" Биспецифическое антитело, которое специфично связывается с IV и II cубдоменами внеклеточного домена HER2 человека
EP3840781A1 (en) * 2018-08-22 2021-06-30 Denali Therapeutics Inc. Anti-her2 polypeptides and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2021533779A5 (cg-RX-API-DMAC7.html)
KR101522954B1 (ko) 항체 중쇄불변부위의 이종이중체 고효율 형성을 유도하는 ch3 도메인 변이체 쌍, 이의 제조방법, 및 용도
AU2015357053B2 (en) Domain-exchanged antibody
JP2022551969A5 (cg-RX-API-DMAC7.html)
JP2021534220A5 (cg-RX-API-DMAC7.html)
IL269395B1 (en) Immunoconjugations of anti–PD–1 antibody with IL–2 or IL–15 mutation
EP2964676A1 (en) Anti-c-met tandem fc bispecific antibodies
CN107001468A (zh) Cd3结合结构域
JP2019502712A5 (cg-RX-API-DMAC7.html)
JP2024150674A5 (cg-RX-API-DMAC7.html)
US20230192887A1 (en) Engineered anti-her2 bispecific proteins
KR20130041968A (ko) 디술피드 안정화 ― Fv 단편을 포함하는 이중특이적 항체
JP2024537779A5 (cg-RX-API-DMAC7.html)
JP2024113040A5 (cg-RX-API-DMAC7.html)
KR20210042326A (ko) 조작된 Fc-항원 결합 도메인 작제물에 관련된 조성물 및 방법
JP2025124718A5 (cg-RX-API-DMAC7.html)
JP2025527160A (ja) 多重特異性抗体およびその使用
JP2024546129A5 (cg-RX-API-DMAC7.html)
JP2024534118A5 (cg-RX-API-DMAC7.html)
CA3229542A1 (en) Anti-her2 antibodies and methods of use thereof
JP2024534824A5 (cg-RX-API-DMAC7.html)
KR20210043583A (ko) 조작된 Fc-항원 결합 도메인 작제물에 관련된 조성물 및 방법
US20240392035A1 (en) Engineered anti-her2 bispecific proteins
JP2024543942A5 (cg-RX-API-DMAC7.html)
RU2024120734A (ru) Антигенсвязывающая молекула, специфически связывающаяся с psma и cd3, и ее фармацевтическое применение